Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196001 · ClinicalTrials.gov registry record
Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 35
- Enrollment target
NCT00196001: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00196001 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00196001 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Males and females may exhibit different responses to testing of adrenal function. The hormones responsible for controlling adrenal function are ACTH (adrenocorticotropic hormone or corticotropin) and CRH (corticotropin-releasing hormone). Adrenal function is tested with an ACTH stimulation test. ACTH stimulates the adrenal glands to produce cortisol. Cortisol levels are measured, and a certain peak level indicates normal adrenal gland function. Females may produce more cortisol in response to ACTH testing than males. This difference may be due to certain proteins, called G proteins. The hormones controlling adrenal function, ACTH and CRH, work through G proteins. Females may have more G proteins than males allowing for the increased cortisol response to ACTH stimulation. The investigators speculate that: 1. There may be differences in adrenal responsiveness to ACTH stimulation testing between healthy males and females. 2. ACTH and CRH induce their own function. 3. Sex differences in adrenal responsiveness to ACTH stimulation testing may be related to sex differences in G protein expression. In this study, cortisol, a hormone produced by the adrenal glands, will be measured before and after the administration of ACTH. This study will also measure G proteins. G proteins are found in the white blood cells. White blood cells from females may have more active G proteins than white blood cells from males. Sex differences may be augmented after exposure to ACTH.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-04 |
What the finished NCT00196001 record still lists
NCT00196001 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00196001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00196001 about?
NCT00196001 is a clinical study titled "Adrenocorticotropic Hormone (ACTH) Stimulation and G Protein". Males and females may exhibit different responses to testing of adrenal function. The hormones responsible for controlling adrenal function are ACTH (adrenocorticotropic hormone or corticotropin) and CRH (corticotropin-releasing hormone). Adrenal function is tested with an ACTH stimulation test. ACT...
What is the current status of trial NCT00196001?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2005-07. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT00196001?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia